A supraphysiologic (>95th percentile) rise in plasma lipids in pregnancy may serve as a marker for "prelipemia" in the same way that gestational diabetes is a marker for prediabetes. To qualify as prelipemic, subjects with an abnormal lipid rise antepartum must return to normal postpartum but may have other identifying characteristics. This paper describes the antepartum-postpartum changes of lipoprotein lipids and apoproteins at 34 to 38 weeks of gestation and 6 and 20 weeks postpartum in 23 subjects with physiologic and six subjects with supraphysiologic plasma lipid increases during pregnancy. These results are compared to measurements in 23 nonpregnant controls matched for weight, age, and race. In subjects with a physiologic antepartum lipid rise, postpartum total triglyceride and very low density lipoprotein (VLDL) lipids (cholesterol and triglyceride) and apo B returned to baseline within 6 weeks. In contrast, low density lipoprotein (LDL) showed a slow postpartum decline in lipids and apo B with elevations remaining at 20 weeks postpartum. High density lipoprotein (HDL) cholesterol concentrations, elevated in pregnancy, remained elevated at 6 weeks postpartum, but fell to baseline by 20 weeks postpartum. HDL triglyceride and apo A-l concentrations, both elevated in pregnancy, returned to baseline by 6 weeks postpartum. A supraphysiologic triglyceride rise in pregnancy was associated with a slower return of total triglycerides and VLDL to baseline, reduced HDL cholesterol ante-and postpartum, atypical changes in LDL cholesterol during pregnancy and postpartum, and evidence of hyperlipidemia among family members. Two subjects with hypercholesterolemia in the nonpregnant state showed no marked exaggeration of total or LDL cholesterol concentrations in pregnancy. The data support the hypothesis that a supraphysiologic rise in plasma triglyceride concentrations in late pregnancy may serve as a marker of prelipemia. Proof of the hypothesis requires further investigation and longer follow-up. (Arteriosclerosis 4:407-417, July/August 1984) G lucose intolerance and hyperlipidemia are physiologic accompaniments of normal pregnancy. 12 With respect to glucose homeostasis, it is well known that some women manifest overt diabetes under the stress of pregnancy but revert to normal after delivery. The deterioration of glucose homeo-From the Northwest Lipid Research stasis in pregnancy, known as gestational diabet e s , 1 3 4 is considered to be a form of prediabetes because it predicts later progression to overt diabetes with a high degree of accuracy. 4 It is not yet known if a similar deterioration of lipid homeostasis occurs in pregnancy, reverts to normal postpartum, and predicts the appearance of overt nongestational hyperlipidemia years later. Such a condition might be termed "prelipemia" and if identified would provide an important tool to study the natural history of hyperlipidemia from its earliest stages.
monstrable normolipidemia before or after pregnancy. Relatives of these subjects were examined for evidence of familial hyperlipidemia. The distinction between physiologic and supraphysiologic antepartum increases in lipoprotein lipids in pregnancy was made on the basis of the 95th percentile outpoints for lipoprotein triglyceride and cholesterol concentrations in late gestation that we have recently described. 5 
Methods

Subjects
Twenty-three pregnant women with a physiologic plasma lipid increase in pregnancy were recruited for this study from the classes of the Childbirth Education Association (CEA) in Seattle and King County. Six other pregnant women with supraphysiologic lipid increases in pregnancy were referred or found through surveys. Two of these subjects, one hypertriglyceridemic (Subject DR), and one hypercholesterolemic (Subject AM), were identified in the original CEA survey. All subjects gave informed written consent. A physiologic increase in plasma lipids in pregnancy was defined as a total plasma triglyceride and cholesterol concentration less than the 95th percentile at 36 weeks of gestation (387 mg/dl for triglyceride and 318 mg/dl for cholesterol). 5 A supraphysiologic increase in plasma lipids in pregnancy was defined as a total plasma triglyceride or cholesterol concentration at or above the 95th percentile at 36 weeks of gestation. The pregnant subjects were compared with 23 nonpregnant subjects matched for age and Quetelet Index (body mass index calculated as weight/height 2 x 1000) with the 20-week postpartum body mass index of the study subjects used for matching to controls. Control subjects were drawn from a random sample of female Pacific Northwest Bell Company employees whose characteristics were described previously. 8 " 8 The nonpregnant controls and 20-week postpartum subjects having antepartum physiological increases in blood lipids were closely matched for age, weight, height, and body mass index (Table 1) . Women with supraphysiologic lipid increases were generally heavier and had a higher Quetelet Index.
Length of gestation was estimated from the first day of the last menstrual period. Pregnant subjects were studied within 2 weeks of the antepartum target week and within 1 week of the postpartum target week. All subjects were free-living and consuming their customary diets; there was no systematic attempt to restrict calories in these subjects. All fasting glucose concentrations were normal in the pregnant subjects (mean 72.6 ± 1.6 mg/dl, range 60-87) and in nonpregnant subjects (91.5 ± 7.6 mg/dl, range 79-108). No medications except multivitamins were taken during pregnancy. All newborn infants were healthy and of normal weight (mean 3581 g ± 87.6, range 2727-3949 g), except one who was anencephalic. The lipid and apoprotein measurements in the mother of this infant were typical. Of the women with physiological hyperlipidemia, 19 women breastfed postpartum and four did not. None took oral contraceptives during the postpartum study period. One other woman (Subject EW) was studied before, as well as during and after, pregnancy. Her results are considered separately. She was normoglycemic and delivered a normal infant weighing 3580 g. The lactational status of the women with supraphysiologic lipid increases are noted in the tables or text. None used oral contraception postpartum. 
Blood Sampling
Blood samples in pregnant and postpartum women were obtained by a research nurse in each subject's home to minimize the effects of stress on fuel and lipoprotein homeostasis. Nonpregnant subjects came to the Northwest Lipid Research Clinic for blood drawing. All subjects had fasted for 12 to 14 hours before the sampling. About 35 ml of venous blood were obtained from subjects who were sitting. The blood for lipid analysis contained 1.5 mg EDTA per ml blood and was kept on ice until centrifuged in the laboratory. The blood for glucose estimation was collected in tubes containing 2.5 mg sodium fluoride and 2.0 mg potassium oxalate per ml blood.
Lipoprotein and Apoproteln Analyses
Plasma samples were overlain with 0.9% saline and ultracentrifuged in a 40.3 rotor at 40,000 rpm at 17° C for 18 hours. 9 The top 2 ml were analyzed as very low density lipoprotein (VLDL). The bottom fraction was brought to a measured 5 ml with saline and analyzed as the d > 1.006 fraction. Another 3 ml of whole plasma was treated with heparin and MnCLg to precipitate VLDL and low density lipoprotein (LDL), allowing measurement of high density lipoprotein (HDL) lipids in the supernatant. 9 ' 10 The apo B content of the supernatant fraction never exceeded 2 mg/dl by immunoassay. LDL lipid concentrations were determined as the difference between the d < 1.006 infranatant and HDL. Triglyceride and cholesterol were measured using the AutoAnalyzer II method. 9 Apolipoprotein B (apo B) was measured in total plasma and VLDL by a double antibody radioimmu-noassay as previously described. 11 LDL apo B was calculated as the difference between total plasma and VLDL apo B. Apolipoprotein A-l was measured on whole plasma by a radial immunodiffusion method after tetramethylurea delipidation. 12 The ratios of triglyceride/cholesterol and lipid/apoprotein in each lipoprotein fraction are presented as indices of lipoprotein composition.
Statistical Analyses
The mean, standard deviation, and median described lipoprotein lipids, apoproteins and ratios for the nonpregnant controls and the antepartum and postpartum subjects. Nonparametric statistical methods were used for significance testing because of the small sample sizes. Wilcoxon's matched pairs test 13 was performed to determine if significant differences existed between antepartum and postpartum measurements and between 6-and 20-week postpartum values. The Wilcoxon rank sum test 13 was used to detect differences between controls and antepartum, 6-week, and 20-week postpartum subjects. Mean values and 95% confidence intervals were used to graphically illustrate antepartum-topostpartum changes. Table 2 presents the antepartum-postpartum lipoprotein observations in subjects with physiologic hyperlipidemia in pregnancy and matched nonpregnant controls. Selected lipoprotein lipid and apoprotein changes are illustrated in Figure 1 . Ratios of lipoprotein lipids and apoproteins are presented in Table 3 . Total triglyceride concentrations in late gestation were significantly elevated (3.5-fold) above nonpregnant control values, but were only 8 and 4 mg/dl higher at 6 and 20 weeks postpartum, respectively, a nonsignificant elevation. In contrast, whole plasma cholesterol concentrations in pregnancy were 50% higher than control values and remained 25% and 13% higher at 6 and 20 weeks postpartum, respectively.
Results
Physiologic Hyperllpldemla In Pregnancy
VLDL triglyceride, cholesterol, and apo B concentrations in pregnancy were all significantly higher than postpartum and control observations ( Table 2) . Postpartum concentrations were slightly below control levels, significantly for cholesterol. The relationships of VLDL constituents expressed as ratios were not significantly different comparing antepartum and postpartum observations (Table 3 ). However, the triglyceride/cholesterol ratio was higher at all of these times compared to controls.
In LDL in pregnancy, triglyceride and cholesterol were 438% and 47% above control levels, respectively. Postpartum LDL triglyceride and cholesterol concentrations declined gradually, but remained significantly above control levels at 20 weeks, by 61.5% and 16.5%, respectively. LDL apo B was significantly elevated in pregnancy, 38% above controls, and was even higher postpartum by 70% and 44% above controls at 6 and 20 weeks, respectively. Triglyceride enrichment of LDL relative to cholesterol and apo B was particularly marked in pregnancy and declined postpartum ( Table 3 ). The triglyceride/cholesterol ratio remained significantly greater than controls at 20 weeks postpartum while the triglyceride/apo B ratio was similar to controls.
In HDL, triglyceride was increased 2.4-fold in pregnancy and fell to a level slightly below controls at 6 and 20 weeks postpartum. Cholesterol was 23% above the control level in pregnancy, 17% above controls at 6 weeks postpartum, and equal to the control level at 20 weeks postpartum. Apo A-l concentrations were elevated significantly in pregnancy, 35% above control, but were at the same levels as controls at 6 and 20 weeks postpartum. As a result of these changes, HDL was triglyceride-rich and cholesterol-poor in pregnancy (Table 3) , cholesterol-rich at 6 weeks postpartum, and triglyceride-poor at 20 weeks postpartum.
Observations were made on total plasma triglyceride, VLDL, LDL, and HDL cholesterol and glucose before pregnancy as well as during pregnancy and postpartum in Subject EW ( Figure 2 ). EW was taking Orthonovum oral contraception until 18 days before the pregnancy measurement, which was 1 month before conception. A gradual fall in plasma glucose contrasted with a rise in all lipid constituents. Postpartum triglyceride fell to below prepregnancy levels by 6 weeks. HDL cholesterol reached the prepregnancy control level by 20 weeks, while LDL cholesterol at 6 weeks (139 mg/dl) and 20 weeks (115 mg/ dl) was still above the prepregnancy level (99 mg/dl). Figure 2 . Plasma glucose, triglyceride, and cholesterol and lipoprotein cholesterol concentrations in subject EW before, during, and after pregnancy. Glucose declined while all lipids increased throughout pregnancy. Postpartum, triglyceride and VLDL cholesterol fell to slightly below prepregnancy levels by 6 weeks of gestation and HDL cholesterol fell to normal by 20 weeks. LDL cholesterol declined more slowly and remained above prepregnancy levels at 20 weeks postpartum. 
Supraphysiologic Hyperlpidemia in Pregnancy
The results are considered by the individual subject in the text and are summarized in Tables 4 to 6 and Figure 3 . Subject DR was studied in detail (Table  4 and Figure 3 ). She was markedly hypertriglyceridemic and slightly hypercholesterolemic in late gestation as compared to 95th percentile reference values. 5 The VLDL triglyceride level of 382 mg/dl was well above the 95th percentile in pregnancy (246 mg/ dl). The LDL triglyceride and cholesterol concentrations both exceeded the 95th percentile at 36 weeks of gestation, but the relative amounts of her triglyceride, cholesterol, and apo B in LDL remained approximately the same as in the 23 normal subjects ( Table  2 ). Her HDL triglyceride and cholesterol concentrations were markedly reduced in pregnancy, while the apo A-l concentrations remained at a level typical for pregnancy (158 mg/dl).
At 6 weeks postpartum, DR's plasma triglyceride concentrations remained above the 95th percentile, but at 20 and 40 weeks postpartum they fell within the 95th percentile of triglyceride for nonpregnant, nonhormone-using subjects. 6 A similar slow postpartum decline was seen for VLDL triglyceride. LDL tri-glycerides had dropped more abruptly by 6 weeks postpartum, while HDL triglyceride declined slowly. LDL cholesterol showed a continuing decline through 40 weeks postpartum but was within the 95th percentile by 6 weeks postpartum. HDL cholesterol was still low at 6 weeks postpartum, rose by 20 weeks postpartum, but even at 40 weeks postpartum was only marginally above the 5th percentile for HDL cholesterol in nonpregnant women aged 20-29. In contrast, apo A-l concentrations at 6 and 20 weeks postpartum were only slightly below the mean for nonpregnant, nonhormone-treated normal subjects (125 mg/dl). 12 Two years later, subject DR was observed in a second pregnancy at 36 weeks of gestation. Total plasma triglyceride was 400 mg/dl (>95th percentile), LDL cholesterol was 167 mg/dl (<95th percentile), and HDL cholesterol was 48 mg/dl (<10th percentile).
To investigate the possibility that DR's pathophysiological response to pregnancy is due to a familial trait, lipoprotein lipids were determined in her father (aged 61) and mother (aged 62). Results are presented in mg/dl. The father had a total triglyceride of 242 (>90th age-specific percentile), a total-cholesterol of 257 (>75th percentile), an LDL cholesterol of 181 (~90th percenile), and an HDL cholesterol of 37 (~15th percentile). The mother's lipoproteins were close to the median values for her age and sex: total triglyceride, 149; total cholesterol, 227; LDL cholesterol, 175; while her HDL cholesterol, 72 mg, was near the 75th percentile. Thus, there is evidence for elevated total triglyceride and LDL cholesterol in a first degree relative of DR.
Three other subjects with supraphysiologic triglyceride increases in pregnancy are compared to DR in Table 5 and are also illustrated in Figure 3 . One of these women, subject CB, was the mother of two hypertriglyceridemic children with fasting chylomicronemia and plasma triglyceride levels of 6460 and 796 mg/dl at ages 3 and 1, respectively, on an unrestricted diet. CB's parents had triglycerides at the 75th and 90th percentiles and cholesterol at the 75th percentile. 68 CB therefore appears to be an obligate heterozygote for the Type I phenotype. YF's brother (aged 29) had total and LDL cholesterol concentrations (237 and 163 mg/dl, respectively) at or above the age-and sex-specific 95th percentiles (222 and 165 mg/dl) and a total triglyceride concentration (135 mg/dl) >90th percentile. YF's father had average lipoprotein lipid concentrations. Thus, there is an association of hyperlipidemia in a first degree relative of YF. The relatives of FS were not available for study.
All four subjects were below the 95th percentile values for total plasma triglycerides either before pregnancy or 20 weeks postpartum, but were markedly above the 95th percentile in late gestation. All subjects showed a delay in the postpartum decline of total triglyceride concentrations compared with normal subjects, in that at 6 weeks postpartum, total triglyceride concentrations were consistently above the 95th percentile (Table 5 and Figure 3) . Similar trends were observed in VLDL triglyceride and cholesterol (data not shown). Disparate responses were seen among the four subjects with respect to total and LDL cholesterol ante-and postpartum. DR was the only subject showing a combined elevation of triglyceride and cholesterol in pregnancy. All others had abnormal increases only in total and VLDL triglyceride. Another distinction was the LDL cholesterol fall at 6 weeks postpartum in DR, but a rise in the other three. The 20-week postpartum or prepregnancy LDL cholesterol concentrations in these three subjects were also higher than the pregnancy levels. HDL cholesterol concentrations were not as low in subjects FS, YF, and CB as in subject DR, but were near or below the 5th percentiles both ante-and postpartum.
Hypercholesterolemic subject AM is presented in Table 6 and in Figure 3 . She was not on a cholesterol-restricted diet at the time of the study. Total plasma cholesterol concentrations were similar at 6 and 20 weeks postpartum, but were near or above the 95th percentile value. VLDL lipids and apo B were consistently normal (compare the apo B results with those in Table 2 ). The LDL cholesterol concentration was above the 95th percentile at 36 weeks of gestation, 5 fell postpartum to slightly below the 95th percentile at 6 weeks, but exceeded the 95th percentile at 20 weeks. 6 Compared with 6 and 20 weeks postpartum, the LDL cholesterol rise due to pregnancy was 49 to 63 mg/dl. The apo B concentration was about 40 mg/dl above the average at 36 weeks of gestation and 20 weeks postpartum, but increased to 80 mg/dl above the average at 6 weeks postpartum, an exaggeration of the pattern observed in normal subjects at 6 weeks postpartum ( Table 2 ). HDL lipids were fairly typical in this patient; however, apo A-l did not fall postpartum as much as expected.
A familial heterozygous hypercholesterolemic woman with tendonous xanthomas (subject NC) was studied at 37 weeks of gestation and 6 and 20 weeks postpartum. The patient was on a cholesterol-restricted and polyunsaturate-supplemented diet throughout. Total cholesterol was 614 mg/dl and total triglyceride, 232 mg/dl at 37 weeks of gestation. Postpartum, 6-and 20-week total cholesterol concentrations were 554 mg/dl and 530 mg/dl with cholesterol concentrations in VLDL of 20 mg/dl and 24 mg/dl; LDL, of 484 mg/dl and 444 mg/dl; and HDL, of 60 mg/dl and 62 mg/dl. In NC the total cholesterol rise in pregnancy (comparing 36 weeks of gestation and 20 weeks postpartum) was 84 mg/dl, only slightly higher than the total cholesterol increment observed in 23 normal women over the same interval (61 mg/dl). The conclusion from hypecholesterole-mic subjects AM and NC is that plasma cholesterol in hypercholesterolemic subjects is not disproportionately exaggerated in pregnancy in contrast to plasma triglyceride in hypertriglyceridemics.
Discussion
Women with physiologic or supraphysiologic increases in plasma triglyceride or cholesterol in pregnancy were studied at 34 to 38 weeks of gestation and at 6 and 20 weeks or longer postpartum to answer the following questions: How rapidly do the changes in plasma lipoproteins return to normal postpartum in subjects who have a physiologic lipid increase antepartum? Do subjects with supraphysiologic increases antepartum return to normal postpartum in the same manner and do they return to normal at all? Are there identifying characteristics in lipoprotein concentrations or family history that would suggest that the supraphysiologic lipid rise in pregnancy is a pathophysiologic process indicative of a subclinical or prelipemic trait that may eventually progress to overt hyperlipidemia?
In subjects with a physiologic triglyceride rise in pregnancy, plasma total triglyceride and all VLDL constituents reached a baseline level by 6 weeks postpartum essentially identical to nonpregnant con In subjects with a physiologic triglyceride rise in pregnancy, plasma total triglyceride and all VLDL constituents reached a baseline level by 6 weeks postpartum essentially identical to nonpregnant control subjects. All subjects with a supraphysiological triglyceride rise in pregnancy had normal total plasma triglyceride concentrations (<95th percentile) either before pregnancy or by 20 weeks postpartum, but the rate of return to normal postpartum was slower than in normal subjects with plasma triglyceride still elevated at 6 weeks postpartum. It is not known if the excessive triglyceride rise antepartum (and to a lesser degree 6 weeks postpartum) is due to an increased rate of VLDL entry, diminished clearance, or both, and if the mechanism is the same for each individual. Evidence from animal models does indicate that the physiologic hypertriglyceridemia of pregnancy is due to increased VLDL entry into the circulation rather than to a primary impairment of VLDL triglyceride clearance, 14 " 17 with the increase in VLDL secretion due to an estrogen effect. 18 Interestingly, pregnancy does not appear to cause a disproportionate cholesterol increase in total plasma or LDL in subjects with hypercholesterolemia in the nonpregnant state, which indicates that pregnancy may not be useful in identifying latent hypercholesterolemia.
A slow postpartum return to the nonpregnant baseline was observed in the constituents of LDL even in subjects with physiologic hyperlipidemia in pregnancy. In subjects with a physiologic lipid rise antepartum, the postpartum return to baseline was prolonged beyond 20 weeks postpartum and may be as long as 1 to 1.5 years if one assumes a linear rate of decline extrapolated from 6 and 20 weeks (see Figure 2 ). Changes in LDL composition also persisted to at least 20 weeks postpartum, such as an increase in the LDL triglyceride/cholesterol ratio which in this instance mimicked the preceding change in pregnancy. Another interesting feature is that LDL had relatively more lipid and less apo B antepartum and less lipid and more apo B postpartum. There is as yet no information on the mechanism of the antepartum and postpartum LDL elevations and changes in composition. It is tempting to speculate that the persistent postpartum changes in LDL may reflect the regression of maternal fat stores and other tissues with mobilization of cholesterol and an enhanced recycling of esterified cholesterol into LDL.
A contrasting pattern is seen in LDL constituents of subjects with excessive triglyceride increases in pregnancy. In three subjects, LDL cholesterol was reduced in pregnancy, was markedly increased 6 weeks postpartum, and then gradually fell. The reciprocal relationship observed between VLDL and LDL is reminiscent of that seen originally by Lees and Wilson 19 and may be a feature of familial combined hyperlipidemia, 20 a highly atherogenic condition. 21 On the other hand, subject DR possibly represents another form of hypetriglyceridemia, with the simultaneous supraphysiologic rise in LDL and VLDL in pregnancy also suggesting a combined disorder of triglyceride and cholesterol metabolism. The important point is that differing patterns of lipoprotein abnormalities appear to exist among pregnant women with supraphysiologic triglyceride increases in pregnancy and these may reflect differing pathophysiologic and genetic mechanisms. Pure hypercholesterolemia as exemplified by subjects AM and NC contrasted with hypertriglyceridemia in that total and LDL cholesterol were not unduly exaggerated during pregnancy.
In subjects with a physiologic lipid rise antepartum, HDL cholesterol and apo A-l both increased in pregnancy. Postpartum, apo A-l returned to baseline first (within 6 weeks), followed by cholesterol (within 20 weeks). A consistent marker in the subjects with a supraphysiologic triglyceride rise antepartum was the low HDL cholesterol antepartum which did not increase postpartum even when triglycerides had returned to within the 95th percentile. This observation suggests that the reduction in HDL may be the more fundamental abnormality and is a clue that the hypertriglyceridemia of pregnancy is a true pathophysiologic disorder consistent with an underlying prelipemic trait. It is noteworthy that the HDL cholesterol reduction was less marked in the three subjects with changes in LDL reciprocal to VLDL than in the only hypertriglyceridemic subject, DR, in whom both VLDL triglyceride and LDL cholesterol increased to an abnormal degree in pregnancy. An HDL cholesterol reduction intermediate between normal and endogenous hypertriglyceridemia is characteristic of familial combined hyperiipidemia 20 and combined hyperiipidemias in general. 22 -23 A final argument that a supraphysiologic rise in plasma triglyceride antepartum is a pathophysiologic process signifying an underlying prelipemic trait is based on the fact that all three subjects for whom relatives were available show evidence of hyperlipidemia among family members. The difference among the subjects' responses to pregnancy, as well as the available information among relatives, suggests that the designation of prelipemia could represent several distinct and possibly genetic underlying disorders of lipoprotein metabolism. Further investigations of larger numbers of prelipemic women with in-depth family studies are necessary to resolve this question. In addition, long-term follow-up will be necessary to verify the hypothesis that the hyperlipidemic stress of pregnancy can unmask a prelipemic trait. Nonetheless, it is noteworthy that subject CB has remained hyperlipidemic for almost 2 years since delivery, her only normal value having been obtained before the pregnancy we observed.
While the postpartum observations made at specific times and the distinctions between subjects with physiologic and supraphysiologic lipid increases in pregnancy are entirely new, our antepartum observations confirm several previously described features of hyperlipidemia in pregnancy. These include an increase in total and VLDL apo B, 24 little or no change in VLDL composition, 2 2425 an increase in triglyceride content of LDL and HDL, 22425 and an increase in apo A-l. 26 Thus, conclusions drawn from this paper can be considered to be generally representative of the body of information on hyperlipidemia in pregnancy.
The possibility that the hyperlipidemia of pregnancy might confer added arteriosclerosis risk has recently been raised. 2728 While it is true that an increase in LDL cholesterol could enhance arteriosclerosis, usually this change is associated with an apo B-rich 29 and triglyceride-poor LDL, 30 which is the opposite of that seen in pregnancy. In addition, HDL cholesterol and apo A-l concentrations were increased, which may facilitate cholesterol removal from tissues. In light of these results, it is perhaps not surprising that the epidemiologic evidence 31 that arteriosclerosis is more common in multiparous women is inconclusive. It is more likely that the observed lipoprotein changes serve a physiological purpose to support growth of maternal and fetal tissues and production of large quantities of steroid hormones. 5 ' 16 The extent to which the postpartum lipoprotein changes are atherogenic is deserving of further study.
In summary, evidence is presented to support the hypothesis that the hyperlipidemic stress of pregnancy can unmask a latent hypertriglyceridemia, by using as a basis for recognition a triglyceride rise in pregnancy exceeding the 95th percentile. Women with such a supraphysiologic triglyceride rise antepartum may return to normal levels postpartum more slowly than normal, have LDL lipids that change in an atypical manner antepartum and postpartum, have HDL cholesterol concentrations that are persistently low antepartum and postpartum, and have hyperlipidemic family members. In contrast, hypercholesterolemia is not greatly exaggerated in pregnancy. Longterm follow-up studies of women with genetically well-characterized disorders of lipoprotein metabolism are required to determine if an abnormal lipoprotein response in pregnancy can identify prelipemic subjects and distinguish among the major disorders of lipoprotein metabolism. Identification of prelipemia will provide an opportunity to study prospectively the natural progression, potential for atherosclerosis, and possible treatment of hyperlipidemia from early adulthood.
